Angiotech to sell Contour Threads reconstructive surgical products in Europe

By Elaine Rigoli

Tampa, Fla., Aug. 24 - Angiotech Pharmaceuticals, Inc. said it has received CE Mark approval to expand the use for its Contour Threads product line, encompassing aesthetic as well as plastic and reconstructive surgical procedures.

Having already been approved for use in brow, neck and mid-face lift procedures, Angiotech is currently marketing the product for facial procedures through distribution agreements in the European Union.

Angiotech now has the ability to market its product line in Europe for breast lift and nipple repositioning procedures, according to a company news release.

The global market for aesthetics procedures generated more than $15 billion in 2004 and is growing, the release said.

Vancouver, B.C.-based Angiotech is a global specialty pharmaceutical and medical-device company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.